FATE Operating Income Growth
Fate Therapeutics Inc · Operating Income Growth
FATE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported30.56%period ending
FATE TTM Operating Income YoY % (-50.32% → 30.56%)
Year-over-year change
High-resolution chart · PNG
FATE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 30.5568% | |
| 30.4577% | |
| 29.7571% | |
| 11.125% | |
| 1.602% | |
| 5.8684% | |
| -10.3747% | |
| 4.9561% | |
| 19.2018% | |
| 18.8655% | |
| 38.2232% | |
| 33.9857% | |
| 14.0684% | |
| -7.0377% | |
| -42.1173% | |
| -73.1105% | |
| -78.3569% | |
| -75.4261% | |
| -69.4141% | |
| -46.255% | |
| -32.228% | |
| -21.8083% | |
| -27.1605% | |
| -40.0204% | |
| -53.1444% | |
| -56.1877% | |
| -50.1327% | |
| -41.2094% | |
| -38.6181% | |
| -59.0287% | |
| -59.2688% | |
| -66.7644% | |
| -58.057% | |
| -35.834% | |
| -31.793% | |
| -20.2236% | |
| -22.0302% | |
| -19.8914% | |
| -15.0493% | |
| -16.4398% | |
| -10.1666% | |
| -12.1901% | |
| -11.5564% | |
| -12.3622% | |
| -14.9477% | |
| -18.9829% | |
| -40.8996% | |
| -41.8981% | |
| -50.3166% |